Accelerate Diagnostics
AXDX
$0.88
Share price
-1.21%
Change (1 day)
19.19%
Change (1 year)
Categories
Accelerate Diagnostics (AXDX) Fails to deliver data
Key failure to deliver metrics for Accelerate Diagnostics:
- Last SEC data release: 2024-04-30
- Last 15 days FTD volume: $0.03 M
- Last 3 months FTD volume: $0.13 M
- Last year FTD volume: $1.9 M
Failures to deliver for Accelerate Diagnostics (AXDX) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Accelerate Diagnostics (AXDX) - since 2023
Volume in USD (price x number of shares), data since 2023Accelerate Diagnostics (AXDX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.36 M | -75.99% |
| 2023 | $1.53 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $0.10 B | $0.34 B | 🇺🇸 USA |
 Becton Dickinson BDX | $24.38 M | $0.13 B | 🇺🇸 USA |
 PerkinElmer
PKI | $10.73 M | $58.8 M | 🇺🇸 USA |
 Bruker BRKR | $6.63 M | $13.74 M | 🇺🇸 USA |
 NanoString Technologies NSTG | $1.29 M | $3.66 M | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | $0.26 M | $7.88 M | 🇺🇸 USA |